HIV/AIDS programmes and services should be aware about the potensial and relevant risks regarding the influenza A 
(H1N1) virus infection as well it needs to consider plans for prevention and treatment. There is lack of information on clinical interactions between HIV and influenza A (H1N1) virus including whose transmission, complications, and spectrum of illness that the increased risk of complications of influenza A (H1N1) are under investigation.
Pan American Health Organization which is a regional office of the WHO issued Considerations on Influenza A (H1N1) and HIV infection at May 1, 2009. It was stated that the risk of mortality from seasonal influenza is increased among HIV-infected individuals compared with the general population. Therefore, HIV patients need to be considered as a high risk and a priority for antiviral treatment with oseltamivir or zanamivir which shortens illness duration and severity in seasonal influenza.
See the HIV lifecycle, pathophysiology of Influenza and antiviral medication regarding H1N1 influenza such with HIV infection in this blog.
